Synapse

  • About
  • FAQ
  • Reports
  • Contact Us
  • Memorial Sloan Kettering Cancer Center

  • Works
  • Groups
  • People
  • Publications
  • Publishers
  • In Press
Advanced
Search Within

James Huy Nguyen

  • Home
  • Works
  • Groups
  1. "Early Drug Development Service"
Formats
  1. Journal Article (1)
Groups
  1. Department of Medicine (1)
  2. Early Drug Development Service (1)
  3. Solid Tumor Oncology Division (1)
  4. Thoracic Oncology (1)
People
  1. Alexander Drilon (1)
  2. David Hyman (1)
Years
  1. 2018 (1)
Publications
  1. Cancer Discovery (1)
Publishers
  1. American Association for Cancer Research (1)

Results (1)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Repotrectinib (TPX-0005) is a next-generation ROS1/TRK/ALK inhibitor that potently inhibits ROS1/TRK/ALK solvent-front mutations
    Journal Article

    Drilon, A.; Ou, S. H. I.; Cho, B. C.; Kim, D. W.; Lee, J.; Lin, J. J.; Zhu, V. W.; Ahn, M. J.; Camidge, D. R.; Nguyen, J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Follow Us on
    Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

    Legal Disclaimer | Giving to the Library
    © 2022 Memorial Sloan Kettering Cancer Center Library